Unicycive Therapeutics Inc
UNCY5.400USD
+0.130+2.47%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
112.59MMarket Cap
LossP/E TTM
Unicycive Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
-100.00%
EPS(YoY)
-5.65
-341.13%
Analyst Rating
BUY
2025-11-21
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of -100.00%.
What is the Earnings Per Share (EPS) of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -5.647, with a year-on-year change of -341.13%.
What is the net income of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its net income was -37.82M, with a year-on-year change of -20.42%.
What is the net margin of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -2088.57%, with a year-on-year change of --.
What is the Return on Assets (ROA) of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -160.18%, with a year-on-year change of 55.40%.
What is the operating profit of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its operating profit was -32.12M, with a year-on-year change of -54.60%.
What are the current assets of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its current assets were 30.95M, with a year-on-year change of 130.97%.
What are the total assets of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its total assets of Unicycive Therapeutics Inc were 31.67M, with a year-on-year change of 123.16%.
What are the total liabilities of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its total liabilities of Unicycive Therapeutics Inc were 24.24M, with a year-on-year change of 34.65%.
What is the total equity of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its total equity of Unicycive Therapeutics Inc was 7.43M, with a year-on-year change of 295.09%.
What is the net operating income of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its net operating income of Unicycive Therapeutics Inc was -36.73M, with a year-on-year change of -20.25%.
What is the net investment of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its net investment of Unicycive Therapeutics Inc was -72.00K, with a year-on-year change of -500.00%.
What is the net financing of Unicycive Therapeutics Inc?
According to Unicycive Therapeutics Inc's FY2024 earnings report, its net financing of Unicycive Therapeutics Inc was 45.09M, with a year-on-year change of 63.71%.
